GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Moss Genomics Inc (XCNQ:MOSS) » Definitions » Research & Development

Moss Genomics (XCNQ:MOSS) Research & Development : C$0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Moss Genomics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Moss Genomics's Research & Development for the three months ended in Dec. 2024 was C$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was C$0.00 Mil.

Moss Genomics Research & Development Historical Data

The historical data trend for Moss Genomics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moss Genomics Research & Development Chart

Moss Genomics Annual Data
Trend Jun22 Jun23
Research & Development
- -

Moss Genomics Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Moss Genomics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moss Genomics  (XCNQ:MOSS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Moss Genomics Research & Development Related Terms

Thank you for viewing the detailed overview of Moss Genomics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Moss Genomics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Moss Genomics Inc (XCNQ:MOSS) » Definitions » Research & Development
Comparable Companies
TSXV:PTEC TSXV:KOVO XCNQ:AIML TSXV:AJA TSXV:EKG XCNQ:DMED TSXV:CHS XCNQ:TMED XCNQ:NARA TSXV:OKAI VEEV GEHC ASX:PME DOCS TEM TSE:2413 HQY WAY HKSE:02587 BTSG
Traded in Other Exchanges
F73:Germany
Address
1030 West Georgia Street, Suite 908, Vancouver, BC, CAN, V6E 2Y3
Website
https://www.mossgenomics.com
Moss Genomics Inc is an emerging consumer genomics company that provides personalized health, anti-aging, and wellness solutions based on genomic, microbiome, and epigenome data. The company aims to eliminate barriers in healthcare by offering accessible, affordable at-home testing along with easy-to-understand actionable results.
Executives
Lucas Cahill 10% Security Holder

Moss Genomics Headlines

No Headlines